# US 2022/0031805 A1 · Therapeutic method of treatment for inhibiting tumor development using tamm-horsfall glycoprotein (thp) as immunostimulating drug and compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031805 A1
- Document ID: US20220031805A1
- Status: Published application
- Kind: A1
- Application number: 17/450,613
- Filed: 2021-10-12
- Published: 2022-02-03
- Earliest claimed: 2012-02-09
- Assignees: Raúl Enrique MASSONE; Instituto Massone S.A.
- Applicants: Instituto Massone S.A.
- Inventors: Miguel Angel CASTELLANO; José F. GROISMAN; Liliana Ester BALANIAN; Felipe INSERRA; Emilio SOJO; Claudio Fernando WOLFENSON BAND; Elena M. V. de CAVANAGH
- Web page: https://patentgrep.com/patent/US20220031805A1

## CPC

- A61K 38/1709: {from mammals}
- A61K 38/16: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)}
- A61P 35/00: Antineoplastic agents
- A61P 37/04: Immunostimulants
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.

## Claims

### Claim 1

A therapeutic method of treatment of colon cancer and melanoma in a mammal, wherein the colon cancer and melanoma have intratumor vascularization and the intratumor vascularization is retained after the therapeutic treatment, the method comprising parenterally administering to a mammal in need thereof a composition comprising an effective amount of human Tamm-Horsfall glycoprotein, native or pegylated, and a pharmacologically acceptable excipient.

### Claim 2 (depends on 1)

The therapeutic method of treatment according to claim 1, wherein the human Tamm-Horsfall glycoprotein is a human Tamm-Horsfall glycoprotein pegylated with polyethylene glycol (PEG) tresylate.
